ARCHIVES

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

This article is from The Cancer Letter archive.

Vol. 01 No. 22 | May 30, 1975

Download PDF Visit The Full Archive

Related Articles

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007